Home > Insider Trading > Filing (0001209191-11-039367)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1349077	Lisa Kelly	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-07-12	953	$28.84	39,035	No	4	M	Direct
Common Stock	Disposition	2011-07-12	953	$51.22	38,082	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2011-07-12	953	$0.00	953	$28.84

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
954	2007-10-12	2017-07-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,520	Indirect	401(k)

Footnotes

Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $51.22 (range $50.21 to $51.56).
Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 07/12/2007.